AzTrials
AzTrials

Patients Undergoing Anaesthesia InductionKEM-HENNCT06421181

Hemodynamic Effects of Anesthesia Induction

An observational study of Patients Undergoing Anaesthesia Induction, run by Kliniken Essen-Mitte at 1 site in Germany.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The idea of that project is to characterize the hemodynamic changes of a daily used clinical intervention (induction of anesthesia) in a highly controlled environment by two hemodynamic monitoring devices. Read more about this study

Who is it for?
Ages 18 years and older, women only
How many people
30 participants
Where
1 siteGermany
Study dates
14 Jan 2025to 30 Jun 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with the diagnosis of advanced primary ovarian cancer will be screened prior to cytoreductive surgery in cooperation with the colleagues of gynaecological oncology. If the patients are eligible they will be informed to give consent.

Who may be able to join

  • Patients undergoing elective laparotomy in the hospital Evangelische Kliniken Essen-Mitte
  • Due to the invasiveness of the planned surgery there is an indication for an arterial and central-venous line as well as an peridural catheter

Who cannot join

  • Age < 18 years
  • Lack of written informed consent
  • Insufficient language skills
  • Unwillingness to have pseudonymized disease data stored at the study site and lack of consent to share anonymized data as part of the clinical trial
  • American society of anaesthesiologists physical status higher as grade 3
  • congestive heart failure with a grade of 2 or higher according to the New York heart association (NYHA)
Show all 11Show fewer
  • Ischemic cardiopathy with a grade of 2 or higher according to the Canadian cardiovascular society (CCS)
  • Known severe valve pathologies of the heart
  • Chronic kidney disease with dependency of hemodialysis
  • Atrial fibrillation ora trail flutter
  • Pulmonary hypertension

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Aarne Feldheiser, M.D., PhD. contact

+49201174 ext. 31001

a.feldheiser@kem-med.com

Germany1 site, 1 recruiting
  • Evangelische Kliniken Essen-Mitte

    Essen, North Rhine-Westphalia, 45136

    Aarne Feldheiser, M.D., PhD., +49201174 ext. 31001, a.feldheiser@kem-med.com

    Stefan Boland, M.D., +49201174 ext. 31001, s.boland@kem-med.com

    Recruiting

Other trials in Germany

About this study

The idea of that project is to characterize the hemodynamic changes of a daily used clinical intervention (induction of anesthesia) in a highly controlled environment by two hemodynamic monitoring devices. The aim is an advanced hemodynamic profiling of this intervention and additionally screen for changes in flow patterns in an exploratory fashion.

Both devices complement one another in their hemodynamic profiling ability. One device is a continuous monitoring with instant traceable changes and the other an intermittent point-of-care ultrasound/echocardiography device with advanced possibilities for differential diagnostics.

A second purpose is to test the possibility to implement advanced echocardiography in a point-of-care approach during anaesthesia induction and evaluate the time and quality of a comprehensive analysis by a not-certified anaesthetists with an echocardiography device with features of artificial intelligence versus a certified expert.

Read the detailed description

Mortality after surgery is still high and high-risk procedures are associated to high postoperative complication rates. For hemodynamic monitoring, a meta-analysis showed a reduction in mortality and especially for the esophageal Doppler a reduction in postoperative complications. However, the effects reducing mortality and morbidity have to be considered as low. Probably, this is the reason why daily clinical implementation rates of hemodynamic monitoring are low, too.

However, hemodynamic studies only focus on intraoperative optimization, but recent publications suggested that taking preoperative individual hemodynamic values for arterial blood pressure and cardiac index as targets for optimization provides advanced therapeutic options. Lastly, both studies do not provide data about the preoperative values and their changes during the induction of anesthesia.

Our own data confirm that the induction of anesthesia, the establishment of a working epidural and the surgical incision of the abdomen leads to decreased cardiac index and markers of inotropy in otherwise cardiovascular healthy patients. However, the intervention studies and our own data strongly suggest that starting hemodynamic monitoring after the induction of anesthesia or the surgical incision may foreclose that the clinician can guide the hemodynamic therapy towards individualized goals. Additionally, the corrective treatment in this scenario could be different from just vasopressors.

Nevertheless, in contrast to our own data a recent study showed that hypotension in the post-induction period is primarily associated with a decreased vascular tone due to anesthetic agents, suggesting that the appropriate treatment is vasopressors.

A detailed hemodynamic profiling of non-cardiac patients undergoing high-risk cancer surgery prior, during and after the induction of anaesthesia may provide new insights about the effects of anaesthetic drugs, positive pressure ventilation, and changes of sympathetic tone.

Keywords
Hemodynamic monitoring, Point-of-care ultrasound, Point-of-care echocardiography, Anaesthesia induction, Respiratory effects

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Longitudinal change of heart rate assessed in percentages during the induction of anaesthesia

    The heart rate will be monitored continuously to detect any change of it during the induction of anaesthesia. The change will be described in percentages.

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  2. Longitudinal change of arterial blood pressure assessed in percentaqes during the induction of anaesthesia

    The arterial blood pressures will be monitored continuously to detect any change of it during the induction of anaesthesia. The change will be described in percentages.

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  3. Longitudinal change of stroke volume assessed in percentaqes during the induction of anaesthesia

    The stroke volume will be monitored continuously to detect any change of it during the induction of anaesthesia. The change will be described in percentages.

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  4. Longitudinal change of myocardial strain imaging assessed by transthoracic echocardiography during the induction of anaesthesia

    The echocardiographic feature of strain imaging for the analysis of contractile performance of the myocardium will be monitored prior to induction and after induction of anaesthesia to detect any changes

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

Secondary outcomes (8)
  1. Changes in percentages in a comprehensive echocardiographic assessment of the right ventricle and atrium

    The echocardiographic features will be monitored prior to induction and after induction of anaesthesia to detect any changes

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  2. Changes of the left ventricular and atrial volume in percentages assessed by a transthoracic echocardiography

    The echocardiographic parameter will be monitored prior to induction and after induction of anaesthesia to detect any changes.

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  3. Changes of the left ventricular systolic and diastolic function in percentages assessed by a transthoracic echocardiography

    The echocardiographic features will be monitored prior to induction and after induction of anaesthesia to detect any changes

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  4. Changes of function of the cardiac valves assessed by a transthoracic echocardiography

    The echocardiographic features will be monitored prior to induction and after induction of anaesthesia to detect any changes of the cardiac valve functions like increase of regurgitation

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  5. Changes in percentage of the cardiocirculatory flow in an advanced hemodynamic monitoring device based on a pulse-contour methodology in a continuous fashion during induction of anaesthesia

    The haemodynamic features will be monitored prior to the start of induction up to the end of induction of anaesthesia to detect any changes

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  6. Changes of flow profiles of the splanchnic vessels as well as peripheral arteries determined by ultrasound

    The ultrasound features will be monitored prior to induction and after induction of anaesthesia to detect any changes

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  7. Mean systemic filling pressure (MSFP)

    The MSFP will be determined based on the stop-flow-methodology to determine additionally venous return characteristics

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

  8. Baroreceptor sensitivity (BRS)

    BRS will be determined to analyse the impact of drugs of anaesthesia induction on the vegetative nervous system. The assessment is based on invasive measurement of the arterial blood pressure in combination with the electrocardiogram

    Measured: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2024
  2. Study start14 Jan 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion30 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06421181
Sponsor's protocol ID
KEM-HEN
Acronym
KEM-HEN
Status last verified
Jan 2025
First submitted
26 Apr 2024
Last updated
15 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Chong MA, Wang Y, Berbenetz NM, McConachie I. Does goal-directed haemodynamic and fluid therapy improve peri-operative outcomes?: A systematic review and meta-analysis. Eur J Anaesthesiol. 2018 Jul;35(7):469-483. doi: 10.1097/EJA.0000000000000778.

    PubMed 29369117
  • Ripolles-Melchor J, Casans-Frances R, Espinosa A, Abad-Gurumeta A, Feldheiser A, Lopez-Timoneda F, Calvo-Vecino JM; EAR Group, Evidence Anesthesia Review Group. Goal directed hemodynamic therapy based in esophageal Doppler flow parameters: A systematic review, meta-analysis and trial sequential analysis. Rev Esp Anestesiol Reanim. 2016 Aug-Sep;63(7):384-405. doi: 10.1016/j.redar.2015.07.009. Epub 2016 Feb 10. English, Spanish.

    PubMed 26873025
  • Sessler DI, Bloomstone JA, Aronson S, Berry C, Gan TJ, Kellum JA, Plumb J, Mythen MG, Grocott MPW, Edwards MR, Miller TE; Perioperative Quality Initiative-3 workgroup; POQI chairs; Miller TE, Mythen MG, Grocott MP, Edwards MR; Physiology group; Preoperative blood pressure group; Intraoperative blood pressure group; Postoperative blood pressure group. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019 May;122(5):563-574. doi: 10.1016/j.bja.2019.01.013. Epub 2019 Feb 27.

    PubMed 30916004
  • Kouz K, Wegge M, Flick M, Bergholz A, Moll-Khosrawi P, Nitzschke R, Trepte CJC, Krause L, Sessler DI, Zollner C, Saugel B. Continuous intra-arterial versus intermittent oscillometric arterial pressure monitoring and hypotension during induction of anaesthesia: the AWAKE randomised trial. Br J Anaesth. 2022 Oct;129(4):478-486. doi: 10.1016/j.bja.2022.06.027. Epub 2022 Aug 23.

    PubMed 36008202
  • Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, Bertran S, Leone M, Pastene B, Piriou V, Molliex S, Albanese J, Julia JM, Tavernier B, Imhoff E, Bazin JE, Constantin JM, Pereira B, Jaber S; INPRESS Study Group. Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017 Oct 10;318(14):1346-1357. doi: 10.1001/jama.2017.14172.

    PubMed 28973220
  • Nicklas JY, Diener O, Leistenschneider M, Sellhorn C, Schon G, Winkler M, Daum G, Schwedhelm E, Schroder J, Fisch M, Schmalfeldt B, Izbicki JR, Bauer M, Coldewey SM, Reuter DA, Saugel B. Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth. 2020 Aug;125(2):122-132. doi: 10.1016/j.bja.2020.04.094.

    PubMed 32711724
  • Saugel B, Bebert EJ, Briesenick L, Hoppe P, Greiwe G, Yang D, Ma C, Mascha EJ, Sessler DI, Rogge DE. Mechanisms contributing to hypotension after anesthetic induction with sufentanil, propofol, and rocuronium: a prospective observational study. J Clin Monit Comput. 2022 Apr;36(2):341-347. doi: 10.1007/s10877-021-00653-9. Epub 2021 Feb 1.

    PubMed 33523352
  • Middel C, Stetzuhn M, Sander N, Kalkbrenner B, Tigges T, Pielmus AG, Spies C, Pietzner K, Klum M, von Haefen C, Hunsicker O, Sehouli J, Konietschke F, Feldheiser A. Perioperative advanced haemodynamic monitoring of patients undergoing multivisceral debulking surgery: an observational pilot study. Intensive Care Med Exp. 2023 Sep 8;11(1):61. doi: 10.1186/s40635-023-00543-1.

    PubMed 37682496
  • Feldheiser A, Juhl-Olsen P, Nordine M, Stetzuhn M, Wiegank L, Knebel F, Treskatsch S, Berger C. A comprehensive echocardiographic analysis during simulated hypovolaemia: An observational study. Eur J Anaesthesiol. 2023 Aug 1;40(8):578-586. doi: 10.1097/EJA.0000000000001863. Epub 2023 Jun 1.

    PubMed 37265333

Questions about this trial

What is this clinical trial studying?

An observational study of Patients Undergoing Anaesthesia Induction, run by Kliniken Essen-Mitte at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aarne Feldheiser, M.D., PhD. (+49201174 ext. 31001, a.feldheiser@kem-med.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Longitudinal change of heart rate assessed in percentages during the induction of anaesthesia (time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06421181, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2025; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in